Cargando…
Fast Fluorine-18 labeling and preclinical evaluation of novel Mucin1 and its Folate hybrid peptide conjugate for targeting breast carcinoma
BACKGROUND: There is a need to develop new and more potent radiofluorinated peptide and their hybrid conjugates for multiple-receptors targeting properties that overexpress on many cancers. METHODS: We have synthesized MUC1-[(18)F] SFB and MUC1-FA-[(18)F] SFB hybrid conjugates using a convenient and...
Autores principales: | Al Jammaz, I., Al-Otaibi, B., Al-Malki, Y., Abousekhrah, A., Okarvi, S. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973340/ https://www.ncbi.nlm.nih.gov/pubmed/33738611 http://dx.doi.org/10.1186/s41181-021-00127-y |
Ejemplares similares
-
Development of new copper-64 labeled rhodamine: a potential PET myocardial perfusion imaging agent
por: AlHokbany, Norah, et al.
Publicado: (2022) -
A convenient and efficient total solid-phase synthesis of DOTA-functionalized tumor-targeting peptides for PET imaging of cancer
por: Okarvi, Subhani M., et al.
Publicado: (2019) -
Development of the Tumor-Specific Antigen-Derived Synthetic Peptides as Potential Candidates for Targeting Breast and Other Possible Human Carcinomas
por: Okarvi, Subhani M., et al.
Publicado: (2019) -
(18) F-click labeling and preclinical evaluation of a new (18) F-folate for PET imaging
por: Schieferstein, Hanno, et al.
Publicado: (2013) -
Preclinical Evaluation of a Fluorine-18 Labeled Probe
for the Detection of the Expression of PSMA Level in Cancer
por: Guo, Yirui, et al.
Publicado: (2021)